We are live on
!
Find out more
Edgewise Therapeutics
EWTX
EWTX
214 hedge funds and large institutions have $3.72B invested in Edgewise Therapeutics in 2026 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 65 increasing their positions, 66 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
83% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 24
69% more call options, than puts
Call options by funds: $18.7M | Put options by funds: $11.1M
23% more capital invested
Capital invested by funds: $3.02B → $3.72B (+$699M)
10% more funds holding in top 10
Funds holding in top 10: 10 → 11 (+1)
8% more funds holding
Funds holding: 199 → 214 (+15)
2% less repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 66
4.57% less ownership
Funds ownership: 115.07% → 110.5% (-4.6%)
Holders
214
Holders Change
+15
Holders Change %
+7.54%
% of All Funds
2.63%
Holding in Top 10
11
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+10%
% of All Funds
0.14%
New
44
Increased
65
Reduced
66
Closed
24
Calls
$18.7M
Puts
$11.1M
Net Calls
+$7.66M
Net Calls Change
+$6.35M
Top Buyers
Top Sellers
| 1 |
B
Braidwell
Stamford,
Connecticut
|
-$82.6M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$23.2M |
| 3 |
Morgan Stanley
New York
|
-$19.2M |
| 4 |
DM
Deerfield Management
New York
|
-$19M |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$16.5M |
